EPIDERMOLYTIC ICHTHYOSIS

Clinical trials for EPIDERMOLYTIC ICHTHYOSIS explained in plain language.

Never miss a new study

Get alerted when new EPIDERMOLYTIC ICHTHYOSIS trials appear

Sign up with your email to follow new studies for EPIDERMOLYTIC ICHTHYOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Cancer drug repurposed to fight painful, rare skin diseases

Disease control Not yet recruiting

This study is testing if a low dose of an existing cancer drug, erlotinib, can safely reduce the painful skin thickening and scaling caused by rare genetic skin disorders. It will involve 44 adults with confirmed diagnoses of conditions like epidermolytic ichthyosis. The goal is …

Matched conditions: EPIDERMOLYTIC ICHTHYOSIS

Phase: PHASE1, PHASE2 • Sponsor: Northwestern University • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

EPIDERMOLYTIC ICHTHYOSIS

Get alerted when new EPIDERMOLYTIC ICHTHYOSIS trials appear

Cancer drug repurposed to fight painful, rare skin diseases